Search - tctmd.com

Displaying 621 - 640 of 957

Sort: Relevancy | Date

News Daily News

Mortality From Heart Failure Increasing in United States

Michael O'Riordan

May 06, 2019

News Daily News

Analysis Supports Aiming for Lower BP in Patients With Diabetes, Hypertension

Todd Neale

April 29, 2019

News Daily News

Will Less Aggressive Lp(a) Targets Do the Trick? Time and Clinical Trials Will Tell

Yael L. Maxwell

April 24, 2019

News Daily News

No Need for Niacin? Meta-analysis Argues the End Is Nigh

Yael L. Maxwell

April 22, 2019

News Daily News

Younger Type 2 Diabetes Patients Face Higher Mortality and CVD Risks

Michael O'Riordan

April 10, 2019

News Daily News

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

L.A. McKeown

April 03, 2019

News Conference News ACC 2019

Amlodipine the Key Component in Dual BP Therapy in Sub-Saharan Africa: CREOLE

Caitlin E. Cox

March 25, 2019

News Conference News ACC 2019

INFINITY: Aggressive Blood Pressure Lowering May Slow Cerebrovascular Disease in Elderly

L.A. McKeown

March 21, 2019

News Conference News ACC 2019

COACT: Delayed Angiography Does Not Compromise Survival in Cardiac Arrest Patients Without STEMI

L.A. McKeown

March 18, 2019

News Conference News ACC 2019

New Primary Prevention Guidelines Axe Aspirin, Pushing Routine Check-ins, Social Clues Instead

Michael O'Riordan

March 17, 2019

News Daily News

Bempedoic Acid Boosts LDL Cholesterol-Lowering in Statin-Treated CVD Patients: CLEAR Harmony

Michael O'Riordan

March 15, 2019

News Daily News

Cardiometabolic Risk Factors May Boost Effects of Air Pollution, Chinese Study Says

L.A. McKeown

March 12, 2019

News Daily News

Rising Inflammatory Tides: Increasing CRP Levels After ACS Tied to Greater CVD Risks

Michael O'Riordan

March 08, 2019

News Conference News CRT 2019

Renal Denervation With Alcohol Infusions Appears Safe, but Clinical Impact Remains Unproven

Yael L. Maxwell

March 06, 2019

News Daily News

Many CVD Risk Factors Remain Uncontrolled in Men and Women, but Emphasis Differs

Lucy Hicks

February 21, 2019

News Daily News

Quality of CAD Care Varies by Type of Medicare Coverage

Todd Neale

February 20, 2019

News Daily News

Lower Statin Adherence Linked to Higher Mortality Risk, Even Among Patients With Established ASCVD

Lucy Hicks

February 15, 2019

News Daily News

Intensive BP Lowering May Have Cognitive Benefits: SPRINT MIND

Todd Neale

February 04, 2019

News Features

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

Michael O'Riordan

February 01, 2019

News Daily News

Ethnic Variations in Lp(a) Concentrations Challenge Current Risk Thresholds

Yael L. Maxwell

January 25, 2019

Advertisement

Mortality From Heart Failure Increasing in United States

Analysis Supports Aiming for Lower BP in Patients With Diabetes, Hypertension

Will Less Aggressive Lp(a) Targets Do the Trick? Time and Clinical Trials Will Tell

No Need for Niacin? Meta-analysis Argues the End Is Nigh

Younger Type 2 Diabetes Patients Face Higher Mortality and CVD Risks

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

Amlodipine the Key Component in Dual BP Therapy in Sub-Saharan Africa: CREOLE

INFINITY: Aggressive Blood Pressure Lowering May Slow Cerebrovascular Disease in Elderly

COACT: Delayed Angiography Does Not Compromise Survival in Cardiac Arrest Patients Without STEMI

New Primary Prevention Guidelines Axe Aspirin, Pushing Routine Check-ins, Social Clues Instead

Bempedoic Acid Boosts LDL Cholesterol-Lowering in Statin-Treated CVD Patients: CLEAR Harmony

Cardiometabolic Risk Factors May Boost Effects of Air Pollution, Chinese Study Says

Rising Inflammatory Tides: Increasing CRP Levels After ACS Tied to Greater CVD Risks

Renal Denervation With Alcohol Infusions Appears Safe, but Clinical Impact Remains Unproven

Many CVD Risk Factors Remain Uncontrolled in Men and Women, but Emphasis Differs

Quality of CAD Care Varies by Type of Medicare Coverage

Lower Statin Adherence Linked to Higher Mortality Risk, Even Among Patients With Established ASCVD

Intensive BP Lowering May Have Cognitive Benefits: SPRINT MIND

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

Ethnic Variations in Lp(a) Concentrations Challenge Current Risk Thresholds

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content